6533b854fe1ef96bd12af9d9
RESEARCH PRODUCT
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC).
Silvio TripiAmedea Caterina AlessandriOnofrio VuturoMaurizio SoresiGiuseppe MontaltoDi Gaetano GSpadaro AFreni MBruno SSiciliano Rsubject
year | journal | country | edition | language |
---|---|---|---|---|
2005-01-01 |